These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 9858583

  • 1. The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain.
    Lam PY, Sublett JE, Hollenbach AD, Roussel MF.
    Mol Cell Biol; 1999 Jan; 19(1):594-601. PubMed ID: 9858583
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains.
    Bennicelli JL, Fredericks WJ, Wilson RB, Rauscher FJ, Barr FG.
    Oncogene; 1995 Jul 06; 11(1):119-30. PubMed ID: 7624119
    [Abstract] [Full Text] [Related]

  • 5. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
    Barr FG.
    Oncogene; 2001 Sep 10; 20(40):5736-46. PubMed ID: 11607823
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The COOH-terminal transactivation domain plays a key role in regulating the in vitro and in vivo function of Pax3 homeodomain.
    Cao Y, Wang C.
    J Biol Chem; 2000 Mar 31; 275(13):9854-62. PubMed ID: 10734141
    [Abstract] [Full Text] [Related]

  • 11. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene.
    Fredericks WJ, Ayyanathan K, Herlyn M, Friedman JR, Rauscher FJ.
    Mol Cell Biol; 2000 Jul 31; 20(14):5019-31. PubMed ID: 10866659
    [Abstract] [Full Text] [Related]

  • 12. Identification of a new class of PAX3-FKHR target promoters: a role of the Pax3 paired box DNA binding domain.
    Zhang L, Wang C.
    Oncogene; 2007 Mar 08; 26(11):1595-605. PubMed ID: 16964289
    [Abstract] [Full Text] [Related]

  • 13. Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression.
    Tomescu O, Xia SJ, Strezlecki D, Bennicelli JL, Ginsberg J, Pawel B, Barr FG.
    Lab Invest; 2004 Aug 08; 84(8):1060-70. PubMed ID: 15184910
    [Abstract] [Full Text] [Related]

  • 14. PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro.
    Armoni M, Quon MJ, Maor G, Avigad S, Shapiro DN, Harel C, Esposito D, Goshen Y, Yaniv I, Karnieli E.
    J Clin Endocrinol Metab; 2002 Nov 08; 87(11):5312-24. PubMed ID: 12414908
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx.
    Hollenbach AD, Sublett JE, McPherson CJ, Grosveld G.
    EMBO J; 1999 Jul 01; 18(13):3702-11. PubMed ID: 10393185
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture.
    Scheidler S, Fredericks WJ, Rauscher FJ, Barr FG, Vogt PK.
    Proc Natl Acad Sci U S A; 1996 Sep 03; 93(18):9805-9. PubMed ID: 8790412
    [Abstract] [Full Text] [Related]

  • 19. PAX3-FKHR transformation increases 26 S proteasome-dependent degradation of p27Kip1, a potential role for elevated Skp2 expression.
    Zhang L, Wang C.
    J Biol Chem; 2003 Jan 03; 278(1):27-36. PubMed ID: 12401804
    [Abstract] [Full Text] [Related]

  • 20. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene.
    Khan J, Bittner ML, Saal LH, Teichmann U, Azorsa DO, Gooden GC, Pavan WJ, Trent JM, Meltzer PS.
    Proc Natl Acad Sci U S A; 1999 Nov 09; 96(23):13264-9. PubMed ID: 10557309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.